85 related articles for article (PubMed ID: 23202532)
1. Genetic variants of STAT-4 affect the development of graft fibrosis after liver transplantation for HCV-induced liver disease.
Eurich D; Boas-Knoop S; Struecker B; Neuhaus R; Neuhaus P; Bahra M
Transplantation; 2013 Jan; 95(1):203-8. PubMed ID: 23202532
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
3. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
[TBL] [Abstract][Full Text] [Related]
4. Role of mannose-binding lectin-2 polymorphism in the development of acute cellular rejection after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Boas-Knoop S; Yahyazadeh A; Neuhaus R; Somasundaram R; Ruehl M; Puhl G; Neuhaus P; Neumann UP; Bahra M
Transpl Infect Dis; 2012 Oct; 14(5):488-95. PubMed ID: 22650645
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
[TBL] [Abstract][Full Text] [Related]
6. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Kiessling A; Yahyazadeh A; Trautwein C; Wasmuth H; Puhl G; Neuhaus P; Bahra M
J Gastroenterol Hepatol; 2013 Jan; 28(1):153-60. PubMed ID: 22989351
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
[TBL] [Abstract][Full Text] [Related]
10. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of hepatitis C virus infection after liver transplantation.
Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
[TBL] [Abstract][Full Text] [Related]
12. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor gene polymorphism in recurrent hepatitis C infection after liver transplantation.
Ben-Ari Z; Tambur AR; Pappo O; Sulkes J; Pravica V; Hutchinson I; Klein T; Tur-Kaspa R; Mor E
Transplantation; 2006 Feb; 81(3):392-7. PubMed ID: 16477226
[TBL] [Abstract][Full Text] [Related]
14. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
15. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
16. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
[TBL] [Abstract][Full Text] [Related]
17. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
[TBL] [Abstract][Full Text] [Related]
18. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW;
Liver Transpl; 2003 Apr; 9(4):339-47. PubMed ID: 12682883
[TBL] [Abstract][Full Text] [Related]
20. The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.
Zimmermann T; Hoppe-Lotichius M; Körner A; Lautem A; Heise M; Foltys D; Weiler N; Biesterfeld S; Schmidtmann I; Galle PR; Otto G; Schuchmann M
Transpl Int; 2011 Nov; 24(11):1059-67. PubMed ID: 21797939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]